NEW YORK (GenomeWeb News) - Bionas and PRIMACYT said today that they will jointly develop a cell-based assay using human liver cells to predict hepatotoxic effects of drugs and chemicals.
PRIMACYT, based in Schwerin, Germany, will supply the hepatocytes. The hepatocytes will be cultivated on Bionas metabolic chips with chemically defined media from PRIMACYT.
The chips will be evaluated in the Bionas 2500 analyzing system. The hepatocytes can be reused for other experiments in the system, the companies said.
Financial details were not disclosed.